Abstract
The use of therapeutic lasers depends on four basic laser-tissue interactions; photothermal, photochemical (PDT), mechanical and ablative. There is no place for mechanical and ablative interactions in oncology; PDT will be the subject of a further review and the subject of this review is therefore the photothermal reaction. Thermal lasers have been in routine use in oncology for the last 10–15 years. These lasers, emitting in the visible or infra-red parts of the spectrum, are used to produce three basic effects; hyperthermia, coagulation and vaporization. Other energy sources beside lasers can also be used to produce these tissue effects but lasers seem to possess certain basic advantages. In comparison with monopolar or bipolar diathermy and heater probes, lasers can deliver more power, more accurately at the target tissue with better control of damage and a wider range of effects. In comparison with microwave and ultrasound therapy, lasers are again more precise and can be used with more compact and accurate delivery devices. In gastroenterological surgery (as opposed to endoscopy), neurosurgery and gynaecology, laser light can be delivered via a handpiece to cut and coagulate. In ENT and also some applications of gynaecology lasers can also be used via a microscope. In endoscopic surgery laser light is delivered through an optical fibre within the endoscope—this for the time being precludes the use of the CO2 laser for these applications. More recently, the laser fibre can be placed directly within tumour tissue for interstitial thermal therapy of liver metastases, pancreatic tumours and brain tumours. The future use of thermal lasers in oncology depends very much on the results of properly controlled comparative studies against PDT and non-laser thermal devices; in addition their use may well be widened to include some curative procedures; up until now their use has very much been restricted to palliative therapy except where they are used as an adjunctive cutting device alongside conventional curative surgery.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Henriques FC. Studies of thermal injuries.Arch Pathol 1947,43:489–502
Field SB. Hyperthermia in the treatment of cancer.Phys Med Biol 1987,32:789–811
Svaasand LO, Gomer CJ, Morinelli E. On the physical rationale of laser induced hyperthermia.Lasers Med Sci 1990,5:121–7
Matthewson K, Barr H, Tralau C, Bown SG. Low power interstitial Nd-YAG laser photocoagulation: studies in a transplantable fibrosarcoma.Br J Surg 1989,76:378–81
Masters A, Steger AC, Bown SG. Role of interstitial therapy in the treatment of liver cancer.Br J Surg 1991,78:518–23
Masters A, Bown SG. Interstitial laser hyperthermia in the treatment of tumours.Lasers Med Sci 1990,5:129–35
Manoury V, Mordon A, Brunetaud JM. Preliminary results in endoscopic treatment of digestive tumours using a high power pulsed Nd-YAG laser.Lasers Surg Med 1991, Suppl 3: 26
Sultan RA. Tumor ablation by laser in general surgery.Lasers Med Sci 1990,5:185–93
Fischerman K, Lykkegaard-Nielsen MC, Moesgaard F. Laser surgery in the perineal step of abdominal excision of the rectum. Sixth Congress of the International Society for Laser Surgery and Medicine. Jerusalem: Tech-Digest, 1985:8
Laffitte F, Chavoin JP, Ferrarini JM. Tumour ablation in dermatology.Lasers Med Sci 1990,5:195–7
Nims TA, McCaughan JS. Clinical experience with CO2 laser vaporization of neoplasm.Lasers Med Sci 1986,3:265–8
Roux FX, Merienne L, Cioloca C et al. Neurosurgical lasers for tumor removal.Lasers Med Sci 1990,5:241–4
Merienne L, Leriche B, Roux FX, Devaux B. Nd-YAG laser with cerebral endoscopy: preliminary experience in stereotactic conditions.Neurochirurgie 1992, 38:245–7
Personne C, Colchen A, Leroy M et al. Indications and technique for endoscopic lasers resections in bronchology.J Thorac Cardiovasc Surg 1986,91:710–5
Beamis JF Jr, Vergos K, Rebeiz EE, Shapshay SM. Endoscopic laser therapy for obstructing tracheobronchial lesions.Ann Otol Rhinol Laryngol 1991,100:413–9
Maunoury V, Brunetaud JM, Cochelard D et al. Endoscopic palliation for inoperable malignant dysphagia: long-term follow-up.Gut 1992,33:1602–7
Brunetaud JM, Maunoury V, Ducrote P et al. Palliative treatment of rectosigmoid carcinoma by endoscopic laser photocoagulation.Gastroenterology 1987,92:663–8
Brunetaud JM, Maunoury V, Cochelard D et al.Laser Therapy in Rectosigmoid Tumours. New York: McGraw-Hill, 1993:131–40.
Dumon JF. Une endoprothèse trachéobronchique spécifique.Rev Mal Respir 1990,7:223–9
Van Eyken P, Hiele M, Fevery J et al. Comparative study of low power neodymium-YAG laser interstitial hyperthermia versus ethanol injection for controlled hepatic tissue destruction.Lasers Med Sci 1991,6:35–41
Chapman R. Low power interstitial photocoagulation of uterine leiomyomas by KTP/YAG laser.Lasers Med Sci 1994,9:37–46
Author information
Authors and Affiliations
Additional information
This paper is a revised and updated version of a talk given at ‘Lasers in Medicine: Facing 1992’, the final meeting of the European Community Concerted Action Programme on Medical Laser Development, in Amsterdam 29 November–1 December 1991.
Rights and permissions
About this article
Cite this article
Brunetaud, J.M., Mordon, S., Maunoury, V. et al. Non-PDT Uses of lasers in oncology. Laser Med Sci 10, 3–8 (1995). https://doi.org/10.1007/BF02133156
Issue Date:
DOI: https://doi.org/10.1007/BF02133156